Literature DB >> 32769149

Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al.

Alfred Hyoungju Kim1, Jeffrey A Sparks2, Ali Duarte-García3, Elizabeth R Graef4, Jean W Liew5, Maximilian F Konig6.   

Abstract

Entities:  

Keywords:  arthritis; cardiovascular diseases; hydroxychloroquine; rheumatoid

Year:  2020        PMID： 32769149      PMCID： PMC8075104          DOI： 10.1136/annrheumdis-2020-218680

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

2.  Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.

Authors:  Eli S Rosenberg; Elizabeth M Dufort; Tomoko Udo; Larissa A Wilberschied; Jessica Kumar; James Tesoriero; Patti Weinberg; James Kirkwood; Alison Muse; Jack DeHovitz; Debra S Blog; Brad Hutton; David R Holtgrave; Howard A Zucker
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

3.  Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al.

Authors:  Elizabeth R Graef; Jean W Liew; Alfred Hj Kim; Jeffrey A Sparks
Journal:  Ann Rheum Dis       Date:  2020-05-18       Impact factor: 19.103

4.  QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.

Authors:  Lior Jankelson; Giorgio Karam; Matthijs L Becker; Larry A Chinitz; Meng-Chiao Tsai
Journal:  Heart Rhythm       Date:  2020-05-11       Impact factor: 6.343

5.  QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.

Authors:  Ehud Chorin; Lalit Wadhwani; Silvia Magnani; Matthew Dai; Eric Shulman; Charles Nadeau-Routhier; Robert Knotts; Roi Bar-Cohen; Edward Kogan; Chirag Barbhaiya; Anthony Aizer; Douglas Holmes; Scott Bernstein; Michael Spinelli; David S Park; Carugo Stefano; Larry A Chinitz; Lior Jankelson
Journal:  Heart Rhythm       Date:  2020-05-12       Impact factor: 6.343

6.  Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019.

Authors:  Yishay Szekely; Yael Lichter; Bander Abu Shrkihe; Hila Bruck; Howard S Oster; Sami Viskin
Journal:  Heart Rhythm       Date:  2020-05-05       Impact factor: 6.343

7.  A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic.

Authors:  Marc H Scheetz; Maximilian F Konig; Philip C Robinson; Jeffrey A Sparks; Alfred H J Kim
Journal:  ACR Open Rheumatol       Date:  2020-07-29

Review 8.  Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist.

Authors:  Elizabeth R Graef; Jean W Liew; Alfred Hj Kim; Jeffrey A Sparks; Michael S Putman; Julia F Simard; Emily Sirotich; Francis Berenbaum; Alí Duarte-García; Rebecca Grainger; Carly Harrison; Maximilian F Konig; Peter Korsten; Laurie Proulx; Dawn P Richards; Philip C Robinson; Sebastian E Sattui; Manuel Francisco Ugarte-Gil; Kristen J Young
Journal:  Ann Rheum Dis       Date:  2020-04-15       Impact factor: 27.973

9.  Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.

Authors:  Caleb P Skipper; Katelyn A Pastick; Nicole W Engen; Ananta S Bangdiwala; Mahsa Abassi; Sarah M Lofgren; Darlisha A Williams; Elizabeth C Okafor; Matthew F Pullen; Melanie R Nicol; Alanna A Nascene; Kathy H Hullsiek; Matthew P Cheng; Darlette Luke; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Lauren E Kelly; Ilan S Schwartz; Ryan Zarychanski; Emily G McDonald; Todd C Lee; Radha Rajasingham; David R Boulware
Journal:  Ann Intern Med       Date:  2020-07-16       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.